Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Photodynamic Laser Therapy for Lesions in the Airway

What Predicts Long-Term Survival After Heart Transplantation

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,

Joshua E. Rosen, BASc, Hari B

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Castigliano M. Bhamidipati, DO, MS, George J

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

The Efficacy of Restaging Endobronchial Ultrasound in Patients With Non-Small Cell Lung Cancer After Preoperative Therapy Basil S. Nasir, MBBCh, Ayesha.

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Joshua E. Rosen, BASc, Jacquelyn G. Hancock, BS, Anthony W

Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database Seth B. Krantz, MD, Waseem Lutfi, BS, Kristine Kuchta, MS, Chi-Hsiung.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Management of Subcutaneous Emphysema After Pulmonary Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Daniel C. Thomas, MD, MPH, Justin D. Blasberg, MD, Brian N

Importance of Lymph Node Dissection in Thymic Carcinoma

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy Pamela Samson, MD, MPHS,

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

It’s All in the “Swerve of the Curve”

The Removal of Chest Tubes Despite an Air Leak or a Pneumothorax

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Treatment Outcomes of Patients With Different Subtypes of Large Cell Carcinoma of the Lung Yung-Han Sun, MS, Shih-Wei Lin, PhD, Chih-Cheng Hsieh, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Risk of Valve-Related Events After Aortic Valve Repair

Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base

Presentation transcript:

Outcomes for Lung Transplantation for Lung Cancer in the United Network for Organ Sharing Registry Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S. Bryant, MSPH, MD, Anthony W. Kim, MD, MS, Jasleen Kukreja, MD, MPH, David P. Mason, MD, Christian A. Bermudez, MD, Frank C. Detterbeck, MD, Daniel J. Boffa, MD The Annals of Thoracic Surgery Volume 94, Issue 3, Pages 935-941 (September 2012) DOI: 10.1016/j.athoracsur.2012.04.069 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall survival is shown for the bronchoalveolar carcinoma (BAC)/cancer cohort (dashed line; n = 29) compared with the general lung transplantation cohort (solid line; n = 21,524). (HR = hazard ratio.) The Annals of Thoracic Surgery 2012 94, 935-941DOI: (10.1016/j.athoracsur.2012.04.069) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival is shown for bronchoalveolar carcinoma/cancer patients with invasive (dashed line; n = 13) or noninvasive (solid line; n = 14) tumors. (HR = hazard ratio.) The Annals of Thoracic Surgery 2012 94, 935-941DOI: (10.1016/j.athoracsur.2012.04.069) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival is shown for bronchoalveolar carcinoma/cancer patients in the presence (dashed line; n = 7), or absence (solid line; n = 20) of lymph node (LN) metastases. (HR = hazard ratio.) The Annals of Thoracic Surgery 2012 94, 935-941DOI: (10.1016/j.athoracsur.2012.04.069) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions